Skip to main content
Pharmicell Co.,Ltd. logo

Pharmicell Co.,Ltd. — Investor Relations & Filings

Ticker · 005690 ISIN · KR7005690003 KO Manufacturing
Open in API
Filings indexed 275 across all filing types
Latest filing 2022-02-04 Director's Dealing
Country KR South Korea
Listing KO 005690

About Pharmicell Co.,Ltd.

https://www.pharmicell.com/eng/

Pharmicell Co., Ltd. is a biopharmaceutical company specializing in stem cell technology and advanced bio-based materials. The company is a pioneer in regenerative medicine, having developed Hearticellgram-AMI, the world's first approved stem cell therapy for acute myocardial infarction. Its core business includes the development of stem cell therapeutics, a stem cell banking service for adult and cord blood cells, and a line of cosmetics based on stem cell culture media. A significant division focuses on fine chemicals, manufacturing and supplying critical raw materials for the pharmaceutical industry, such as nucleosides, mPEGs, and oligonucleotides for gene therapies. The company also produces eco-friendly flame retardants for industrial use.

Recent filings

Filing Released Lang Actions
최대주주등소유주식변동신고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) from a Korean company (Pharmicell). It details specific share transactions (purchases) made by directors and major shareholders. This falls under the category of 'Director's Dealing' (DIRS) as it reports personal share transactions by company insiders and major shareholders.
2022-02-04 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Services Commission and the Korea Exchange. It details changes in share ownership by a major shareholder (Kim Hyun Soo) and related parties in Pharmicell Co., Ltd. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant ownership thresholds and changes.
2022-01-26 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a formal announcement of a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) by Pharmicell. It details the contract value, the counterparty (Thermo Fisher Scientific), the contract period, and the nature of the goods (Nucleoside). Since this is a specific regulatory disclosure regarding a commercial contract and does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2021-12-21 Korean
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Pharmicell regarding the adjustment of the conversion price for convertible bonds due to a decline in the stock price. This type of disclosure, which details changes to capital structure instruments like convertible bonds, falls under the category of capital and financing updates. It is not a report publication announcement, but rather a direct disclosure of a financial event affecting the company's capital structure.
2021-12-14 Korean
[기재정정]신규시설투자등
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from Pharmicell regarding a correction (amendment) to a previous disclosure about 'New Facility Investment'. It details changes to the investment amount and the investment period. Since it is a specific regulatory announcement regarding corporate capital expenditure and facility investment that does not fit into categories like M&A, dividends, or share issues, it falls under the general regulatory filing category.
2021-12-09 Korean
분기보고서 (2021.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Pharmicell Co., Ltd. covering the period from January 1, 2021, to September 30, 2021. It contains detailed financial data, business operations, management discussions, and capital structure information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2021
2021-11-08 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.